Cui Tao, Li Junpeng, Zhen Ping, Gao Qiuming, Fan Xiaohai, Li Chuangbing
Department of Orthopaedics, Cangzhou Central Hospital, Cangzhou, Hebei 061000, P.R. China.
Department of Surgery (I), Armed Police Engineering University Hospital, Xian, Shaanxi 710000, P.R. China.
Exp Ther Med. 2018 Oct;16(4):3060-3064. doi: 10.3892/etm.2018.6573. Epub 2018 Aug 6.
The application value of Masquelet induced membrane technique for the treatment of rat chronic osteomyelitis was explored. A total of 180 male Sprague-Dawley (SD) rats were randomly divided into sham operation group (control group), chronic osteomyelitis model group (model group) and Masquelet induced membrane therapy + chronic osteomyelitis model group (observation group); 60 rats in each group. A rat model of traumatic osteomyelitis was established using a modified blunt trauma method in model and observation group. All rats in observation group were treated with membrane induction technology while in the control group they were not. Postoperative complications, bone healing time and functional status of the affected limbs were recorded. After surgery, no obvious perioperative complications occurred in most of the rats, except that 5 rats experienced partial necrosis at the edge of the flap, and 3 experienced superficial infection around the incision site in the ilium. Primary bone healing was achieved in 50 rats with an average healing time of 15 weeks. Among them, 38 rats restored weight-bearing function after 20 weeks. Seven rats experienced infection after surgery, but complete bone healing was achieved after treatment with induced membrane technique again. Following treatment with induced membrane technique, the rat body weight, body temperature and the number of bacteria in the wound decreased over time. In conclusion, Masquelet induced membrane technique is effective for the treatment of large bone defects in rats after traumatic osteomyelitis. This technique significantly shortens the treatment cycle. The surgical procedure is simple, and the incidence of postoperative complications is low.
探讨Masquelet诱导膜技术治疗大鼠慢性骨髓炎的应用价值。将180只雄性Sprague-Dawley(SD)大鼠随机分为假手术组(对照组)、慢性骨髓炎模型组(模型组)和Masquelet诱导膜治疗+慢性骨髓炎模型组(观察组),每组60只。模型组和观察组采用改良钝性创伤法建立创伤性骨髓炎大鼠模型。观察组所有大鼠均采用膜诱导技术治疗,对照组未采用。记录术后并发症、骨愈合时间和患肢功能状态。术后,大多数大鼠未出现明显的围手术期并发症,除5只大鼠皮瓣边缘出现部分坏死,3只大鼠髂骨切口周围出现浅表感染。50只大鼠实现一期骨愈合,平均愈合时间为15周。其中,38只大鼠在20周后恢复负重功能。7只大鼠术后出现感染,但再次采用诱导膜技术治疗后实现完全骨愈合。采用诱导膜技术治疗后,大鼠体重、体温和伤口细菌数量随时间下降。综上所述,Masquelet诱导膜技术治疗创伤性骨髓炎后大鼠大骨缺损有效。该技术显著缩短治疗周期。手术操作简单,术后并发症发生率低。